Serious adverse events · People with P. vivax malaria1
1 finding from 1 review
Other adverse events · People with P. vivax malaria1
1 finding from 1 review
Severe adverse events · People with P. vivax malaria1
1 finding from 1 review
Other adverse events · People with P. vivax malaria1
1 finding from 1 review
Feasibility and engagement: lost to · patients with acute psychiatric disorders
Day hospital showed no clear difference in feasibility and engagement: lost to compared with inpatient (moderate certainty).
1 finding from 1 review
Extent of hospital care: 1. duration of index admission · patients with acute psychiatric disorders
1 finding from 1 review
Unemployed (at end of study) · patients with acute psychiatric disorders
Day hospital may leads to lower unemployed (at end of study) compared with inpatient (low certainty).
1 finding from 1 review
Quality of Life Manchester Short Assessment (MANSA) · patients with acute psychiatric disorders
1 finding from 1 review
Treatment satisfaction: average overall role score ‐ at discharge CAT ‐ Client Assessment of Treatment · patients with acute psychiatric disorders
1 finding from 1 review
Hospital admissions · patients with people with schizophrenia near or on discharge
DAY HOSPITAL showed no clear difference in service use: 1a. Admitted to hospital during study ‐ by 6 months compared with OUT‐PATIENT CARE (moderate certainty).
3 findings from 1 review
RR 0.58 [0.26, 1.33]
2 studies · 110 participants
Moderate
RR 0.73 [0.54, 1]
2 studies · 242 participants
Low
RR 0.71 [0.56, 0.89]
2 studies · 242 participants
Moderate
Global state: 1a. Number lost to · patients with people with schizophrenia near or on discharge
DAY HOSPITAL showed no clear difference in global state: 1a. Number lost to compared with OUT‐PATIENT CARE (moderate certainty).
2 findings from 1 review
Social functioning: 2a. Unemployed ‐ by 6 months · patients with people with schizophrenia near or on discharge
DAY HOSPITAL may leads to lower social functioning: 2a. Unemployed ‐ by 6 months compared with OUT‐PATIENT CARE (low certainty).
1 finding from 1 review
Social functioning: 2b. Unemployed ‐ beyond 12 months · patients with people with schizophrenia near or on discharge
DAY HOSPITAL showed no clear difference in social functioning: 2b. Unemployed ‐ beyond 12 months compared with OUT‐PATIENT CARE (moderate certainty).
1 finding from 1 review
Treatment success as defined by the authors · people with Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain frequency or change in pain frequency · people with Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
At least 30% reduction in pain · people with Crohn's disease
It is very uncertain whether 100 mg olorinab 3 times/day changes pain intensity (30% reduction in weekly AAPS) compared with 25 mg olorinab 3 times/day (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with Crohn's disease
1 finding from 1 review
Tooth whitening - assessed by the dentist · Adults (>=18 years) undergoing home-based bleaching (including tetracycline- and smoking-stained teeth, any baseline shade)
It is very uncertain whether 18% CP paint-on gel (4x/day) changes tooth whitening - assessed by the dentist compared with 18% CP paint-on gel (2x/day) (very low certainty).
1 finding from 1 review
Persistent bacteriuria · children with acute pyelonephritis
Short duration (3 to 4 days) showed no clear difference in persistent bacteriuria after treatment compared with long duration (7 to 14 days) IV therapy (low certainty).
1 finding from 1 review
Recurrent UTI within 6 months · children with acute pyelonephritis
Short duration (3 to 4 days) showed no clear difference in recurrent UTI within 6 months compared with long duration (7 to 14 days) IV therapy (moderate certainty).
1 finding from 1 review